Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance
Phytotherapy Research · 2024-01 · 38 (1) · 59-73
DOI: 10.1002/ptr.8021 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2023-10-05. Written by Biao Wang and 6 co-authors. Institution: School of Pharmacy, Sichuan College of Traditional Chinese Medicine, Mianyang, China. Major MEDLINE topics: Clinical Relevance, Stilbenes. Cited 19 times so far (Crossref); 125 references. Funded by: National Natural Science Foundation of China, Postdoctoral Research Project of Sichuan Province, Research Center for the Collaborative Development of TCM Culture in Sichuan.
Abstract (original language)
Pathological pain, a multifaceted and debilitating ailment originating from injury or post‐injury inflammation of the somatosensory system, poses a global health challenge. Despite its ubiquity, reliable therapeutic strategies remain elusive. To solve this problem, resveratrol, a naturally occurring nonflavonoid polyphenol, has emerged as a potential beacon of hope owing to its anti‐inflammatory, antioxidant, and immunomodulatory capabilities. These properties potentially position resveratrol as an efficacious candidate for the management of pathological pain. This concise review summaries current experimental and clinical findings to underscore the therapeutic potential of resveratrol in pathological pain, casting light on the complex underlying pathophysiology. Our exploration suggests that resveratrol may exert its analgesic effect by the modulating pivotal signaling pathways, including PI3K/Akt/mTOR, TNFR1/NF‐κB, MAPKs, and Nrf2. Moreover, resveratrol appears to attenuate spinal microglia activation, regulate primary receptors in dorsal root sensory neurons, inhibit pertinent voltage‐gated ion channels, and curb the expression of inflammatory mediators and oxidative stress responses. The objective of this review is to encapsulate the pharmacological activity of resveratrol, including its probable signaling pathways, pharmacokinetics, and toxicology pertinent to the treatment of pathological pain. Hopefully, we aim to map out promising trajectories for the development of resveratrol as a potential analgesic.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Pharmacy, Sichuan College of Traditional Chinese Medicine, Mianyang, China.
- State Key Laboratory of Southwestern Chinese Medicine Resources, State Administration of Traditional Chinese Medicine Key Laboratory of Traditional Chinese Medicine Regimen and Health, School of Pharmacy and College of…
- Department of Ophthalmology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Funding
- National Natural Science Foundation of China
- Postdoctoral Research Project of Sichuan Province
- Research Center for the Collaborative Development of TCM Culture in Sichuan
- Science & Technology Department of Sichuan Province
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Sichuan Provincial Health Commission
- Xinglin Scholar Research Promotion Project of Chengdu University of TCM
- State Scholarship Fund from China Scholarship Council (CSC)
Cite
APA
Wang, B., Jiang, H. M., Qi, L. M., Li, X., Huang, Q., Xie, X., & Xia, Q. (2024). Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance. Phytotherapy Research, 38(1), 59-73. https://doi.org/10.1002/ptr.8021
Vancouver
Wang B, Jiang HM, Qi LM, Li X, Huang Q, Xie X, et al. Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance. Phytotherapy Research. 2024;38(1):59-73. doi:10.1002/ptr.8021
BibTeX
@article{Wang2024,
author = {Wang, Biao and Jiang, Hai-Mei and Qi, Lu-Ming and Li, Xiang and Huang, Qun and Xie, Xin and Xia, Qing},
title = {Deciphering resveratrol's role in modulating pathological pain: From molecular mechanisms to clinical relevance},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {1},
pages = {59--73},
doi = {10.1002/ptr.8021}
}
EUVIMED